{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T06:42:46Z","timestamp":1769236966286,"version":"3.49.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T00:00:00Z","timestamp":1135036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,20]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Oligodeoxynucleotides containing CpG motifs (CpG-ODNs) can protect against eosinophilic airway inflammation in asthma. Previously we have found that parenteral or mucosal administration of CpG-ODNs is effective in preventing (as well as reversing established) disease. In this study, we examined the effect of oral CpG-ODNs on the development of immune tolerance. Using an ovalbumin (OVA)-induced murine model of asthma, we found that CpG-ODNs, administered orally around the time of sensitization, prevented eosinophilic airway inflammation in a dose-dependent manner. Although oral co-administration of CpG-ODNs with OVA (known to induce tolerance) did not significantly change the inhibition of OVA-induced airway eosinophilia, it did modulate OVA-specific immunoglobulin responses: oral administration of OVA alone suppressed OVA-specific IgG1 production, but only mice that received CpG-ODNs demonstrated enhanced levels of OVA-specific IgG2c. Finally, we examined whether oral administration of CpG-ODNs, alone or with OVA, could reverse established eosinophilic airway inflammation. Again, neither OVA nor CpG-ODNs alone modulated established eosinophilic airway inflammation, but a combination of the OVA and CpG-ODNs successfully desensitized the mice. This desensitization was associated with suppression of OVA-specific IgE and enhancement of OVA-specific IgG2c production. These findings provide the first indication that oral administration of CpG-ODNs is effective in preventing and reversing antigen-induced eosinophilic airway inflammation. CpG-ODNs may be useful as a component of oral immunotherapy to promote tolerance in established asthma.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.03003.x","type":"journal-article","created":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T16:32:25Z","timestamp":1135096345000},"page":"249-259","source":"Crossref","is-referenced-by-count":35,"title":["Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice"],"prefix":"10.1093","volume":"143","author":[{"given":"K","family":"Kitagaki","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Occupational Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T R","family":"Businga","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Occupational Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J N","family":"Kline","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Occupational Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,12,20]]},"reference":[{"key":"2022010522204277200_b1","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.160.6.2555","article-title":"Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma","volume":"160","author":"Kline","year":"1998","journal-title":"J Immunol"},{"key":"2022010522204277200_b2","doi-asserted-by":"crossref","first-page":"L1137","DOI":"10.1152\/ajplung.00073.2003","article-title":"Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure","volume":"285","author":"Jain","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2022010522204277200_b3","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.4049\/jimmunol.162.10.6284","article-title":"Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides","volume":"162","author":"Sur","year":"1999","journal-title":"J Immunol"},{"key":"2022010522204277200_b4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1172\/JCI119523","article-title":"CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract","volume":"100","author":"Schwartz","year":"1997","journal-title":"J Clin Invest"},{"key":"2022010522204277200_b5","doi-asserted-by":"crossref","first-page":"L170","DOI":"10.1152\/ajplung.00402.2001","article-title":"Treatment of established asthma in a murine model using CpG oligodeoxynucleotides","volume":"283","author":"Kline","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2022010522204277200_b6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1067\/mai.2002.122156","article-title":"Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma","volume":"109","author":"Santeliz","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"2022010522204277200_b7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1471-4906(01)02055-5","article-title":"Atopic disorders: a vaccine around the corner?","volume":"22","author":"Wohlleben","year":"2001","journal-title":"Trends Immunol"},{"key":"2022010522204277200_b8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1146\/annurev.iy.12.040194.004113","article-title":"Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens","volume":"12","author":"Weiner","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"2022010522204277200_b9","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.159.9.4484","article-title":"TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia","volume":"159","author":"Haneda","year":"1997","journal-title":"J Immunol"},{"key":"2022010522204277200_b10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0165-2478(97)00155-7","article-title":"Pereira de Siqueira AL, Mengel J, Gomes E, Ficker SM, Caetano de Faria AM. Prevention of lung eosinophilic inflammation by oral tolerance","volume":"61","author":"Russo","year":"1998","journal-title":"Immunol Lett"},{"key":"2022010522204277200_b11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/intimm\/10.4.387","article-title":"High-dose oral tolerance prevents antigen-induced eosinophil recruitment into the mouse airways","volume":"10","author":"Nakao","year":"1998","journal-title":"Int Immunol"},{"key":"2022010522204277200_b12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1165\/ajrcmb.24.5.4320","article-title":"Suppression of asthma-like responses in different mouse strains by oral tolerance","volume":"24","author":"Russo","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022010522204277200_b13","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.164.10.5236","article-title":"Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL\/6 mice","volume":"164","author":"Karachunski","year":"2000","journal-title":"J Immunol"},{"key":"2022010522204277200_b14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm0602-625","article-title":"Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells","volume":"8","author":"Zuany-Amorim","year":"2002","journal-title":"Nat Med"},{"key":"2022010522204277200_b15","doi-asserted-by":"crossref","first-page":"7054","DOI":"10.4049\/jimmunol.161.12.7054","article-title":"Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice","volume":"161","author":"Broide","year":"1998","journal-title":"J Immunol"},{"key":"2022010522204277200_b16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0264-410X(00)00208-5","article-title":"Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants","volume":"19","author":"McCluskie","year":"2000","journal-title":"Vaccine"},{"key":"2022010522204277200_b17","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0091-6749(99)70022-9","article-title":"CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma","volume":"104","author":"Kline","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"2022010522204277200_b18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000024303","article-title":"CpG DNA as a Th1 trigger","volume":"121","author":"Heeg","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"2022010522204277200_b19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni941","article-title":"CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells","volume":"4","author":"Liu","year":"2003","journal-title":"Nat Immunol"},{"key":"2022010522204277200_b20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1996.tb32561.x","article-title":"TH2-type cytokines in asthma","volume":"796","author":"Kay","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"2022010522204277200_b21","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.4049\/jimmunol.149.9.2977","article-title":"IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones","volume":"149","author":"Parronchi","year":"1992","journal-title":"J Immunol"},{"key":"2022010522204277200_b22","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","article-title":"IL-4 directs the development of Th2-like helper effectors","volume":"145","author":"Swain","year":"1990","journal-title":"J Immunol"},{"key":"2022010522204277200_b23","first-page":"1260","article-title":"Immunomodulatory Effects of CpG Oligodeoxynucleotides on Established Th2 Responses","volume":"9","author":"Kitagaki","year":"2002","journal-title":"Clin Diagn Laboratory Immunol"},{"key":"2022010522204277200_b24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1067\/mai.2003.1646","article-title":"Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice","volume":"112","author":"Gerhold","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"2022010522204277200_b25","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.4049\/jimmunol.164.11.5575","article-title":"Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator","volume":"164","author":"Shirota","year":"2000","journal-title":"J Immunol"},{"key":"2022010522204277200_b26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mai.2002.126660","article-title":"Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity","volume":"110","author":"Horner","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"2022010522204277200_b27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/cimm.2000.1665","article-title":"Induction of oral tolerance in the primed immune system: influence of antigen persistence and adjuvant form","volume":"202","author":"Leishman","year":"2000","journal-title":"Cell Immunol"},{"key":"2022010522204277200_b28","doi-asserted-by":"crossref","first-page":"S712","DOI":"10.1067\/mai.2003.84","article-title":"Immunotherapy of allergic disease","volume":"111","author":"Frew","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"2022010522204277200_b29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/ajrccm\/148.4_Pt_1.1102","article-title":"Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea","volume":"148","author":"Nakajima","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"2022010522204277200_b30","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.182.5.1527","article-title":"Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice","volume":"182","author":"Gavett","year":"1995","journal-title":"J Exp Med"},{"key":"2022010522204277200_b31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI5155","article-title":"Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation","volume":"103","author":"Hansen","year":"1999","journal-title":"J Clin Invest"},{"key":"2022010522204277200_b32","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.4049\/jimmunol.162.4.2375","article-title":"Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma","volume":"162","author":"Randolph","year":"1999","journal-title":"J Immunol"},{"key":"2022010522204277200_b33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2222.1994.tb00917.x","article-title":"A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients","volume":"24","author":"Giovane","year":"1994","journal-title":"Clin Exp Allergy"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.03003.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/143\/2\/249\/42075784\/j.1365-2249.2005.03003.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/143\/2\/249\/42075784\/j.1365-2249.2005.03003.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T20:59:44Z","timestamp":1706821184000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/143\/2\/249\/6457896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,20]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,12,20]]},"published-print":{"date-parts":[[2005,12,20]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.03003.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,12,20]]}}}